NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome

Molecular and Cellular Biology

Volumn 30, Issue 4, 2010, Pages 1097-1105

  Alard, Amandine ^a   Fabre, Bertrand ^a   Anesia, Rodica ^a   Marboeuf, Catherine ^a   Pierre, Philippe ^b   Susini, Christiane ^a   Bousquet, Corinne ^a   Pyronnet, Stéphane ^a,c  

^a INSERM   (France)

^b CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAP BINDING PROTEIN; COMPLEMENTARY DNA; DICOUMAROL; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4G; INITIATION FACTOR 4GI; MESSENGER RNA; PROTEASOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISSOCIATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; RNA TRANSLATION; TRANSLATION INITIATION; TRANSLATION REGULATION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; EUKARYOTIC INITIATION FACTOR-4G; HUMANS; MICE; NAD(P)H DEHYDROGENASE (QUINONE); NADPH DEHYDROGENASE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PEPTIDE INITIATION FACTORS; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN STABILITY;

EUKARYOTA;

EID: 75749106648     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00868-09     Document Type: Article

References (29)

1. Asher, G., Z. Bercovich, P. Tsvetkov, Y. Shaul, and C. Kahana. 2005. 20S proteasomal degradation of ornithine decarboxylase is regulated by NQO1. Mol. Cell 17:645-655.
2. Asher, G., J. Lotem, L. Sachs, C. Kahana, and Y. Shaul. 2002. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc. Natl. Acad. Sci. U. S. A. 99:13125-13130.
3. Asher, G., P. Tsvetkov, C. Kahana, and Y. Shaul. 2005. A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73. Genes Dev. 19:316-321.
4. Azar, R., S. Najib, H. Lahlou, C. Susini, and S. Pyronnet. 2008. Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1. Cell. Mol. Life Sci. 65:3110-3117.
5. Baugh, J. M., and E. V. Pilipenko. 2004. 20S proteasome differentially alters translation of different mRNAs via the cleavage of eIF4F and eIF3. Mol. Cell 16:575-586.
6. Baugh, J. M., E. G. Viktorova, and E. V. Pilipenko. 2009. Proteasomes can degrade a significant proportion of cellular proteins independent of ubiquitination. J. Mol. Biol. 386:814-827.
7. Constantinou, C., M. Bushell, I. W. Jeffrey, V. Tilleray, M. West, V. Frost, J. Hensold, and M. J. Clemens. 2003. p53-induced inhibition of protein synthesis is independent of apoptosis. Eur. J. Biochem. 270:3122-3132.
8. Cormier, P., S. Pyronnet, J. Morales, O. Mulner-Lorillon, N. Sonenberg, and R. Bellé. 2001. eIF4E association with 4E-BP decreases rapidly following fertilization in sea urchin. Dev. Biol. 232:275-283.
9. Cowan, J. L., and S. J. Morley. 2004. The proteasome inhibitor, MG132, promotes the reprogramming of translation in C2C12 myoblasts and facilitates the association of hsp25 with the eIF4F complex. Eur. J. Biochem. 271:3596-3611.
10. Cullen, J. J., M. M. Hinkhouse, M. Grady, A. W. Gaut, J. Liu, Y. P. Zhang, C. J. Weydert, F. E. Domann, and L. W. Oberley. 2003. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism. Cancer Res. 63:5513-5520.
11. Reference deleted.
12. Galés, C., D. Sanchez, M. Poirot, S. Pyronnet, L. Buscail, D. Cussac, L. Pradayrol, D. Fourmy, and S. Silvente-Poirot. 2003. High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. Oncogene 22:6081-6089.
13. Garate, M., R. P. Wong, E. I. Campos, Y. Wang, and G. Li. 2008. NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep. 9:576-581.
14. Gingras, A. C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913-963.
15. Gradi, A., H. Imataka, Y. V. Svitkin, E. Rom, B. Raught, S. Morino, and N. Sonenberg. 1998. A novel functional human eukaryotic translation initiation factor 4G. Mol. Cell. Biol. 18:334-342.
16. Hoyt, M. A., and P. Coffino. 2004. Ubiquitin-free routes into the proteasome. Cell. Mol. Life Sci. 61:1596-1600.
17. Lahlou, H., M. Fanjul, L. Pradayrol, C. Susini, and S. Pyronnet. 2005. Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol. Cell. Biol. 25:4034-4045.
18. Lewis, A., M. Ough, L. Li, M. M. Hinkhouse, J. M. Ritchie, D. R. Spitz, and J. J. Cullen. 2004. Treatment of pancreatic cancer cells with dicumarol induces cytotoxicity and oxidative stress. Clin. Cancer Res. 10:4550-4558.
19. Lyn-Cook, B. D., Y. Yan-Sanders, S. Moore, S. Taylor, B. Word, and G. J. Hammons. 2006. Increased levels of NAD(P)H:quinone oxidoreductase 1 (NQO1) in pancreatic tissues from smokers and pancreatic adenocarcinomas: a potential biomarker of early damage in the pancreas. Cell Biol. Toxicol. 22:73-80.
20. Madari, H., D. Panda, L. Wilson, and R. S. Jacobs. 2003. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol. Cancer Res. 63:1214-1220.
21. Morley, S. J., and V. M. Pain. 2001. Proteasome inhibitors and immunosuppressive drugs promote the cleavage of eIF4GI and eIF4GII by caspase-8-independent mechanisms in Jurkat T cell lines. FEBS Lett. 503:206-212.
22. Nevins, T. A., Z. M. Harder, R. G. Korneluk, and M. Holcík. 2003. Distinct regulation of internal ribosome entry site-mediated translation following cellular stress is mediated by apoptotic fragments of eIF4G translation initiation factor family members eIF4GI and p97/DAP5/NAT1. J. Biol. Chem. 278:3572-3579.
23. Ohlmann, T., M. Rau, V. M. Pain, and S. J. Morley. 1996. The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E. EMBO J. 15:1371-1382.
24. Prévôt, D., D. Décimo, C. H. Herbreteau, F. Roux, J. Garin, J. L. Darlix, and T. Ohlmann. 2003. Characterization of a novel RNA-binding region of eIF4GI critical for ribosomal scanning. EMBO J. 22:1909-1921.
25. Prévôt, D., J. L. Darlix, and T. Ohlmann. 2003. Conducting the initiation of protein synthesis: the role of eIF4G. Biol. Cell 95:141-156.
26. Pyronnet, S., H. Imataka, A. C. Gingras, R. Fukunaga, T. Hunter, and N. Sonenberg. 1999. Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E. EMBO J. 18:270-279.
27. Ross, D., and D. Siegel. 2004. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol. 382: 115-144.
28. Schmidt, E. K., G. Clavarino, M. Ceppi, and P. Pierre. 2009. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods 6:275-277.
29. Shenberger, J. S., L. Zhang, M. K. Hughlock, T. Ueda, R. Watanabe-Fukunaga, and R. Fukunaga. 2007. Roles of mitogen-activated protein kinase signal-integrating kinases 1 and 2 in oxidant-mediated eIF4E phosphorylation. Int. J. Biochem. Cell Biol. 39:1828-1842.